44 related articles for article (PubMed ID: 16420942)
1. Automated Segmentation of CT-guided Ablation Margins in Colorectal Liver Metastases: How We Move Forward to a Standardization of Ablation Zone Assessment.
Sofocleous CT
Radiology; 2023 Apr; 307(2):e223276. PubMed ID: 36719295
[No Abstract] [Full Text] [Related]
2. Optimal imaging before local therapy of colorectal liver metastases.
Granata V; Petrillo A; Setola SV; Izzo F; Fusco R
Lancet Oncol; 2024 Mar; 25(3):e100. PubMed ID: 38423053
[No Abstract] [Full Text] [Related]
3. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement by Charnsangavej et al.
Chapman WC; Hoff PM; Strasberg SM
Ann Surg Oncol; 2006 Oct; 13(10):1269-70. PubMed ID: 16952024
[No Abstract] [Full Text] [Related]
4. Colorectal cancer recurrence in the liver: detection by PET.
Yasuda S; Makuuchi Y; Sadahiro S; Mukai M; Tokunaga N; Tajima T; Shohtsu A
Tokai J Exp Clin Med; 1998 Oct; 23(4):167-71. PubMed ID: 10359505
[TBL] [Abstract][Full Text] [Related]
5. [Massive liver metastases from colorectal cancer].
Figueras J
Cir Esp; 2005 Jun; 77(6):313-4. PubMed ID: 16420942
[No Abstract] [Full Text] [Related]
6. Radiological staging of colorectal liver metastases.
Ong KO; Leen E
Surg Oncol; 2007 Jul; 16(1):7-14. PubMed ID: 17499498
[TBL] [Abstract][Full Text] [Related]
7. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
Laurens ST; Oyen WJ
PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
[TBL] [Abstract][Full Text] [Related]
8. Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.
Strasberg SM; Dehdashti F
J Surg Oncol; 2010 Dec; 102(8):955-9. PubMed ID: 21165998
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography and colorectal carcinoma: an update.
Tzimas GN; Koumanis DJ; Meterissian S
J Am Coll Surg; 2004 Apr; 198(4):645-52. PubMed ID: 15051018
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
